Werewolf Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell HOWL and other ETFs, options, and stocks.About HOWL
Werewolf Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. The firm offers Predator Technology which focuses on immune targeting and activation.
CEODaniel J. Hicklin
CEODaniel J. Hicklin
Employees46
Employees46
HeadquartersWatertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded2017
Founded2017
Employees46
Employees46
HOWL Key Statistics
Market cap44.61M
Market cap44.61M
Price-Earnings ratio-0.57
Price-Earnings ratio-0.57
Dividend yield—
Dividend yield—
Average volume699.90K
Average volume699.90K
High today$0.9653
High today$0.9653
Low today$0.89
Low today$0.89
Open price$0.925
Open price$0.925
Volume725.79K
Volume725.79K
52 Week high$2.38
52 Week high$2.38
52 Week low$0.595
52 Week low$0.595
Stock Snapshot
With a market cap of 44.61M, Werewolf Therapeutics(HOWL) trades at $0.95. The stock has a price-to-earnings ratio of -0.57.
On 2025-11-17, Werewolf Therapeutics(HOWL) stock traded between a low of $0.89 and a high of $0.97. Shares are currently priced at $0.95, which is +6.6% above the low and -1.7% below the high.
Werewolf Therapeutics(HOWL) shares are trading with a volume of 725.79K, against a daily average of 699.9K.
During the past year, Werewolf Therapeutics(HOWL) stock moved between $0.60 at its lowest and $2.38 at its peak.
During the past year, Werewolf Therapeutics(HOWL) stock moved between $0.60 at its lowest and $2.38 at its peak.
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own HOWL. This list is generated using Robinhood data, and it’s not a recommendation.